Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Cardiovascular Events Following the Cessation of Xanthine Oxidase Inhibitors: A Cohort Analysis

  • By

  • Joseph Magagnoli

  • Tammy H. Cummings

  • Meenakshi Ambati

  • S. Scott Sutton

  • Jayakrishna Ambati

  • December 26, 2025

Share

Original Source(s)

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study

  • by Joseph Magagnoli, Tammy H. Cummings, Meenakshi Ambati, S. Scott Sutton, Jayakrishna Ambati

  • December 26, 2025

Related Content

Status, challenges, and prospects of artificial intelligence application in gout diagnosis and treatment, drug research and development, and disease monitoring

Patients’ knowledge influences practice via attitudes toward hyperuricaemia: a mediation analysis

Allopurinol, gout, and cardiovascular risk